MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2020-21)
- Udyam number
- UDYAM-TS-02-0006229
Unicon Pharma Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹3.58 Cr
▲ 61.36% YoY
Net profit · FY 2024
₹12.08 Lakh
Net margin 3.4%
EBITDA · FY 2024
₹18.07 Lakh
EBITDA margin 5%
Authorised capital
₹8 Cr
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹8.76 Cr
Secured borrowings
Company age
6 yrs
Est. 2020
Employees · EPFO
45
Provident fund records
About Unicon Pharma Private Limited
Data last updated:
Unicon Pharma Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 16 September 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24100TG2020PTC143959. Its GSTIN is 36AACCU6754C1ZC (Telangana).
The company has an authorised share capital of ₹8 Cr and a paid-up capital of ₹1 Lakh. It is led by directors including Udaya Kiran Perla (Managing Director) and Ramesh Kumar Modukuri.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 1st Floor 81/10 Street No. 1 Patrika Nagar Madhapur, Hyderabad, Telangana, India – 500081.
As per the financials filed for FY 2024, the company reported a revenue of ₹3.58 Cr. For the same year it recorded a net profit of ₹12.08 Lakh (net margin 3.4%) and EBITDA of ₹18.07 Lakh (EBITDA margin 5%).
The company has about 45 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Unicon Pharma. As per MCA filings, the company has open charges of ₹8.76 Cr on record.
Unicon Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-02-0006229). For more details, the company can be reached via its website uniconpharma.com.
Company details
CIN U24100TG2020PTC143959
Registration Number 143959
Incorporation Date 16 September 2020
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
MSME Classification Micro
Udyam Registration UDYAM-TS-02-0006229
Key People
Udaya Kiran Perla Managing Director Ramesh Kumar Modukuri Director Ravi Kumar Kollipora Director Recognitions & Rankings of Unicon Pharma
Contact details
Unicon Pharma Private Limited's registered office is in Hyderabad, Telangana. Its website is uniconpharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address1st Floor 81/10 Street No. 1 Patrika Nagar Madhapur, Hyderabad, Telangana, India – 500081
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Unicon Pharma Private Limited, buy the company report.
Comprehensive company report
Unicon Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Unicon Pharma operates one associated brand: Unicon Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Provides life science consulting and recruitment services. | uniconpharma.com |
Business activity
The main business activities of Unicon Pharma are manufacturing and professional, scientific and technical. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products and other professional, scientific and technical activities. 2 activity segments are registered with the MCA.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | |
| M | Professional, Scientific and Technical | M9 | Other professional, scientific and technical activities |
To see the full business activity and turnover split of Unicon Pharma Private Limited, buy the company report.
Financials of Unicon Pharma Private Limited
FY 2024 filings availableUnicon Pharma Private Limited reported revenue of ₹3.58 Cr for FY 2024.
Revenue · FY 2024
₹3.58 Cr
Net profit · FY 2024
₹12.08 Lakh margin 3.4%
EBITDA · FY 2024
₹18.07 Lakh margin 5%
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹18.07 Lakh | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹12.08 Lakh | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 5% | |||
| Net Profit Margin | 3.4% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Unicon Pharma Private Limited, buy the company report.
Board of directors of Unicon Pharma Private Limited
Unicon Pharma has 3 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ramesh Kumar Modukuri | Director | 16 Sep 2020 | 6 Years 1 Months | Current |
| Udaya Kiran Perla | Managing Director | 16 Sep 2020 | 6 Years 1 Months | Current |
| Ravi Kumar Kollipora Also directs: Unicon Wealth Management LLP, Eliteone Group Management Services LLP, Grovel Life Private Limited and 5 more | Director | 18 Nov 2020 | 5 Years 11 Months | Current |
Peer comparison
Unicon Pharma Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| TPS Laboratories Pvt Ltd | ₹3.59 Cr (FY 2017) | -16.0% | Hyderabad, Telangana, India | |||
| Primodia Chemicals and Pharmaceuticals Private Limited | ₹3.59 Cr (FY 2024) | 18.0% | Hyderabad, Telangana, India | |||
| Medisun Lifescience Private Limited | ₹3.59 Cr (FY 2024) | 2.0% | Surat, Gujarat, India | |||
| Unicon Pharma Private Limitedthis company | ₹3.58 Cr (FY 2024) | ₹12.08 Lakh | 3.4% | Hyderabad, Telangana, India | ||
| Palmer Laboratories Private Limited | ₹3.58 Cr (FY 2025) | -8.0% | Ahmedabad, Gujarat, India |
To see the full peer comparison of Unicon Pharma Private Limited, buy the company report.
Auditor
Unicon Pharma Private Limited is audited by RAJESHKORUPROLU for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| RAJESHKORUPROLU | FY 2023 | 236836 |
Shareholding
The shareholding of Unicon Pharma Private Limited is on record for 3 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Unicon Pharma Private Limited, buy the company report.
Charges & borrowings
Open charges
₹8.76 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 31 Dec 2024 | 101025408 | Others | ₹8 Cr | Open | |
| 27 Mar 2024 | 100933630 | Axis Bank Limited | ₹76.48 Lakh | Open |
Total charge records: 2 View all charges
Legal cases
No court or tribunal cases involving Unicon Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Unicon Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Unicon Pharma has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AACCU6754C1ZC | Telangana | Active | 01 Oct 2020 |
To see the full GST registrations and return filing status of Unicon Pharma Private Limited, buy the company report.
Recent activity
Unicon Pharma Private Limited has 5 board changes on record since 2020: 3 appointments and 2 cessations. The latest: Geetha Kode ceased to be Director on 19 Dec 2022.
Charges
A charge with Others amounted to Rs. 8.00 Cr with Charge ID 101025408 was registered on 31 Dec 2024.
AGM
Unicon Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Unicon Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad.
Charges
A charge with Axis Bank Limited amounted to Rs. 0.76 Cr with Charge ID 100933630 was registered on 27 Mar 2024.
Ceased
Geetha Kode ceased to be Director.
Ceased
Ravi Kumar Kollipora ceased to be Additional Director.
Appointed
Ravi Kumar Kollipora was appointed as Director.
Appointed
Ramesh Kumar Modukuri was appointed as Director.
Appointed
Udaya Kiran Perla was appointed as Managing Director.
Incorporation
16 Sep 2020
Unicon Pharma Private Limited was registered on 16 Sep 2020 with Roc Hyderabad & aged 6 years 1 month as per MCA records.
Frequently asked questions
Unicon Pharma is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 16 September 2020 (6+ years old) and is registered under CIN U24100TG2020PTC143959.
Unicon Pharma has 3 current directors:
- Udaya Kiran Perla - Managing Director
- Ramesh Kumar Modukuri - Director
- Ravi Kumar Kollipora - Director
The latest financial statements of Unicon Pharma on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Unicon Pharma is 36AACCU6754C1ZC, registered in Telangana.
The CIN (Corporate Identification Number) of Unicon Pharma is U24100TG2020PTC143959. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Unicon Pharma was incorporated on 16 September 2020, making it 6+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Unicon Pharma by revenue are TPS Laboratories Pvt Ltd, Primodia Chemicals and Pharmaceuticals Private Limited, Medisun Lifescience Private Limited, Palmer Laboratories Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Geetha Kode ceased to be Director on 19 Dec 2022. Ravi Kumar Kollipora ceased to be Additional Director on 31 Dec 2021. Ravi Kumar Kollipora was appointed as Director on 18 Nov 2020. Unicon Pharma has 5 board changes on record in total.
Yes, Unicon Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-TS-02-0006229).
Unicon Pharma can be reached through the website uniconpharma.com. Its registered office is in Hyderabad, Telangana, India.
The registered office of Unicon Pharma is at 1st Floor 8110 Street No. 1 Patrika Nagar Madhapur, Hyderabad, Telangana, India – 500081.